BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 11494227)

  • 1. Clinicopathologic and prognostic significance of matrilysin expression at the invasive front in human colorectal cancers.
    Adachi Y; Yamamoto H; Itoh F; Arimura Y; Nishi M; Endo T; Imai K
    Int J Cancer; 2001 Sep; 95(5):290-4. PubMed ID: 11494227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic significance of the molecular markers in human gastrointestinal cancer].
    Itoh F; Imai K
    Rinsho Byori; 2003 Feb; 51(2):158-67. PubMed ID: 12690634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer.
    Yamamoto H; Iku S; Adachi Y; Imsumran A; Taniguchi H; Nosho K; Min Y; Horiuchi S; Yoshida M; Itoh F; Imai K
    J Pathol; 2003 Feb; 199(2):176-84. PubMed ID: 12533830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human pancreatic adenocarcinomas: clinicopathologic and prognostic significance of matrilysin expression.
    Yamamoto H; Itoh F; Iku S; Adachi Y; Fukushima H; Sasaki S; Mukaiya M; Hirata K; Imai K
    J Clin Oncol; 2001 Feb; 19(4):1118-27. PubMed ID: 11181677
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrilysin (MMP-7) as a significant determinant of malignant potential of early invasive colorectal carcinomas.
    Masaki T; Matsuoka H; Sugiyama M; Abe N; Goto A; Sakamoto A; Atomi Y
    Br J Cancer; 2001 May; 84(10):1317-21. PubMed ID: 11355941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of matrilysin expression with progression and poor prognosis in human pancreatic adenocarcinoma.
    Nakamura H; Horita S; Senmaru N; Miyasaka Y; Gohda T; Inoue Y; Fujita M; Meguro T; Morita T; Nagashima K
    Oncol Rep; 2002; 9(4):751-5. PubMed ID: 12066203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma.
    Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K
    Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of ets-related transcriptional factor E1AF expression with tumour progression and overexpression of MMP-1 and matrilysin in human colorectal cancer.
    Horiuchi S; Yamamoto H; Min Y; Adachi Y; Itoh F; Imai K
    J Pathol; 2003 Aug; 200(5):568-76. PubMed ID: 12898592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coexpression of matrilysin and laminin-5 gamma2 chain may contribute to tumor cell migration in colorectal carcinomas.
    Masaki T; Sugiyama M; Matsuoka H; Abe N; Izumisato Y; Sakamoto A; Atomi Y
    Dig Dis Sci; 2003 Jul; 48(7):1262-7. PubMed ID: 12870781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of human erythrocyte glucose transporter 1 expression at the deepest invasive site of advanced colorectal carcinoma.
    Furudoi A; Tanaka S; Haruma K; Yoshihara M; Sumii K; Kajiyama G; Shimamoto F
    Oncology; 2001; 60(2):162-9. PubMed ID: 11244332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contribution of matrilysin (MMP-7) to the metastatic pathway of human colorectal cancers.
    Adachi Y; Yamamoto H; Itoh F; Hinoda Y; Okada Y; Imai K
    Gut; 1999 Aug; 45(2):252-8. PubMed ID: 10403738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of matrix metalloproteinases 2, 7 and 9 in patients with colorectal cancer.
    Kostova E; Slaninka-Miceska M; Labacevski N; Jakovski K; Trojachanec J; Atanasovska E; Janevski V; Jovanovik R; Janevska V
    Vojnosanit Pregl; 2014 Jan; 71(1):52-9. PubMed ID: 24516991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical impact of matrix metalloproteinase-7 mRNA expression in the invasive front and inner surface of tumor tissues in patients with colorectal cancer.
    Higashiguchi T; Hotta T; Takifuji K; Yokoyama S; Matsuda K; Tominaga T; Oku Y; Yamaue H
    Dis Colon Rectum; 2007 Oct; 50(10):1585-93. PubMed ID: 17676380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of trypsin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma.
    Yamamoto H; Iku S; Itoh F; Tang X; Hosokawa M; Imai K
    Cancer; 2001 Apr; 91(7):1324-31. PubMed ID: 11283933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of matrilysin expression with recurrence and poor prognosis in human esophageal squamous cell carcinoma.
    Yamamoto H; Adachi Y; Itoh F; Iku S; Matsuno K; Kusano M; Arimura Y; Endo T; Hinoda Y; Hosokawa M; Imai K
    Cancer Res; 1999 Jul; 59(14):3313-6. PubMed ID: 10416584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrilysin-2 expression in colorectal cancer is associated with overall survival of patients.
    Hu Q; Yan C; Xu C; Yan H; Qing L; Pu Y; He Z; Li X
    Tumour Biol; 2014 Apr; 35(4):3569-74. PubMed ID: 24318970
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of ets-related transcriptional factor E1AF is associated with tumor progression and over-expression of matrilysin in human gastric cancer.
    Yamamoto H; Horiuchi S; Adachi Y; Taniguchi H; Nosho K; Min Y; Imai K
    Carcinogenesis; 2004 Mar; 25(3):325-32. PubMed ID: 14604892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma.
    Furudoi A; Tanaka S; Haruma K; Kitadai Y; Yoshihara M; Chayama K; Shimamoto F
    Oncology; 2002; 62(2):157-66. PubMed ID: 11914602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic diagnosis of colorectal cancer].
    Itoh F; Imai K
    Hokkaido Igaku Zasshi; 1996 Jan; 71(1):9-14. PubMed ID: 8727369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical molecular markers as predictors of curability of endoscopically resected submucosal colorectal cancer.
    Kaneko I; Tanaka S; Oka S; Yoshida S; Hiyama T; Arihiro K; Shimamoto F; Chayama K
    World J Gastroenterol; 2007 Jul; 13(28):3829-35. PubMed ID: 17657837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.